The Rise of Drug Innovation in China—Implications for Global Access

COMMENT: China is emerging as a global leader in pharmaceutical innovation, with the number of drugs first approved in China rising sharply in recent years. Many of these are first in class or superior to other treatments. This article discusses potential collaborations with U.S. groups, as well as concerns about trial, generalizability, data integrity, and manufacturing standards.—Matthew Naunheim, MD, MBA